Cargando…
Targeting Brain Tumors with Mesenchymal Stem Cells in the Experimental Model of the Orthotopic Glioblastoma in Rats
Despite multimodal approaches for the treatment of multiforme glioblastoma (GBM) advances in outcome have been very modest indicating the necessity of novel diagnostic and therapeutic strategies. Currently, mesenchymal stem cells (MSCs) represent a promising platform for cell-based cancer therapies...
Autores principales: | Yudintceva, Natalia, Lomert, Ekaterina, Mikhailova, Natalia, Tolkunova, Elena, Agadzhanian, Nikol, Samochernych, Konstantin, Multhoff, Gabriele, Timin, Grigoriy, Ryzhov, Vyacheslav, Deriglazov, Vladimir, Mazur, Anton, Shevtsov, Maxim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615766/ https://www.ncbi.nlm.nih.gov/pubmed/34829821 http://dx.doi.org/10.3390/biomedicines9111592 |
Ejemplares similares
-
Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)
por: Shevtsov, Maxim, et al.
Publicado: (2018) -
Mesenchymal Stem Cells and MSCs-Derived Extracellular Vesicles in Infectious Diseases: From Basic Research to Clinical Practice
por: Yudintceva, Natalia, et al.
Publicado: (2022) -
Passing of Nanocarriers across the Histohematic Barriers: Current Approaches for Tumor Theranostics
por: Gareev, Kamil, et al.
Publicado: (2023) -
Recent Advances in Copper-Based Organic Complexes and Nanoparticles for Tumor Theranostics
por: Tsymbal, Sergey, et al.
Publicado: (2022) -
Heat Shock Protein–Peptide and HSP-Based Immunotherapies for the Treatment of Cancer
por: Shevtsov, Maxim, et al.
Publicado: (2016)